Seller record · Telehealth service

Glam Health

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 4 of 8 criteria. S3, pharmacy identification: No pharmacy is named. The site is a single page of plan cards and a quiz, and it has no terms, answers or shipping page. 3 more criteria also fail; see the table below.

At a glance

Glam HealthTelehealth service

4/8criteria passed

Price: Semaglutide from $149, tirzepatide from $175
Sells: compounded semaglutide with B12, compounded tirzepatide with B12, and 1 more
FDA letters: None on file

Visit Glam Health See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A one-page telehealth storefront selling compounded semaglutide and tirzepatide plans with B12, and a compounded NAD+ plan, at starting prices with no subscription required. It publishes no terms, privacy policy, pharmacy, company name or address.

Operating entity No legal entity name appears on the site, which is a single page of plan cards and an eligibility quiz with no contact page, terms or privacy policy.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Glam Health's website
S2	Prescription gating	PASS	Glam Health's quiz step page; Glam Health's website
S3	Pharmacy identification	FAIL	Glam Health's website; Glam Health's terms
S4	Compounding disclosure	FAIL	Glam Health's website; Glam Health's quiz step page
S5	Analytical documentation	FAIL	Glam Health's website
S6	Business address	FAIL	Glam Health's website; Glam Health's contact page; Glam Health's privacy page
S7	Price disclosure	PASS	Glam Health's website
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSEach plan is reviewed by a licensed provider, and the final plan, dosing and price are confirmed after that review.Source: Glam Health's website.

S2PASSThe start consultation button opens a GLP-1 eligibility quiz whose first screen asks what the buyer hopes to improve by losing weight. No payment screen appears before the questions.Source: Glam Health's quiz step page; Glam Health's website.

S3FAILNo pharmacy is named. The site is a single page of plan cards and a quiz, and it has no terms, answers or shipping page.Source: Glam Health's website; Glam Health's terms.

S4FAILThe plan cards describe each medication as compounded, and no page states that a compounded drug is not FDA-approved.Source: Glam Health's website; Glam Health's quiz step page.

S5FAILNo certificate of analysis or lot document is published anywhere on the site.Source: Glam Health's website.

S6FAILNo address of any kind is printed, and the contact, terms and privacy links all return the home page.Source: Glam Health's website; Glam Health's contact page; Glam Health's privacy page.

S7PASSCompounded semaglutide with B12 from $149, compounded tirzepatide with B12 from $175 and compounded NAD+ from $110, with no subscription required. The cards say the final price is confirmed after provider review.Source: Glam Health's website.

S8PASSNo FDA warning letter names Glam Health, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide with B12, compounded tirzepatide with B12, compounded NAD+.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells NAD+

Visit Glam Health

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.